Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC10333 PTP1B-IN-2 Featured
PTP1B-IN-2 is a novel protein tyrosine phosphatase-1B (PTP1B) inhibitor.
More description
DC8129 PTZ-343 Featured
PTZ-343 is a phenothiazine derivative with chemical name: sodium 3-(10H-phenothiazin-10-yl)propane-1-sulfonate.
More description
DC10691 Pyronaridine Featured
Pyronaridine, also known as Malaridine, is an antimalarial drug.
More description
DC12548 PZ-2891 Featured
PZ-2891 is a specific, allosteric, BBB-permeable, orally active Pantothenate kinase (PANK) modulator, acting as both an orthosteric inhibitor (IC50=1.3 nM, hPANK3) and an allosteric activator of PANK3 activity in the presence of acetyl-CoA in biochemical
More description
DC10684 QCC-374 Featured
QCC-374 is prostanoid agonist potentially for the treatment of pulmonary arterial hypertension.
More description
DC26061 Questiomycin A Featured
Questiomycin A is a phenoxazine and a chromophore that has been found in Streptomyces and has antibacterial and anticancer activities.
More description
DC12365 Quinupristin Featured
Quinupristin/dalfopristin, or quinupristin-dalfopristin is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium.
More description
DC10902 QX-77 Featured
QX77 is a chaperone-mediated autophagy (CMA) activator.
More description
DC10053 R1487 Featured
R1487 is a p38 MAP kinase inhibitor with an IC50 of 10nM. It may have potential as a treatment for inflammatory diseases such as rheumatoid arthritis.
More description
DC7322 R1487 Hydrochloride Featured
R1487 is a p38 MAP kinase inhibitor with an IC50 of 10nM. It may have potential as a treatment for inflammatory diseases such as rheumatoid arthritis.
More description
DC10897 R-7050 Featured
R-7050 is a tumor necrosis factor receptor (TNFR) antagonist with greater selectivity toward TNFα.
More description
DC12701 Radiprodil Featured
Radiprodil is an orally active and selective NMDA NR2B antagonist; a potential therapeutic agent in treatment of neuropathic pain and possibly other chronic pain conditions.
More description
DC12385 Relugolix(TAK-385) Featured
Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.
More description
DC7821 Idasanutlin (RG-7388) Featured
RG7388 is an oral, selective, small molecule MDM2 antagonist that inhibits binding of MDM2 to p53.
More description
DC1064 RITA (NSC652287) Featured
RITA (NSC 652287) is a DNA damaging agent with IC50 of 2 nM and 20 nM in A498 and TK-10 cells.
More description
DC12436 RK-287107 Featured
RK-287107 (RK287107) is a novel potent, tankyrase-specific inhibitor with IC50 of 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively, shows no activity against PARP-1.
More description
DC7933 Ro 48-8071 fumarate Featured
Ro 48-8071 fumarate is an inhibitor of OSC(Oxidosqualene cyclase; IC50=6.5 nM) that has low-density lipoprotein (LDL) cholesterol lowering activity.
More description
DC7271 Ro3280 Featured
RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.
More description
DC10759 Roflumilast N-oxide Featured
Roflumilast N-oxide is a phosphodiesterase 4 inhibitor. Roflumilast N-oxide is the active metabolite of roflumilast.
More description
DC7986 RPI-1 Featured
RPI-1 is a cell-permeable ATP-competitive tyrosine kinase inhibitor
More description
DC11467 RR6 Featured
RR6 is a selective, reversible, and competitive vanin inhibitor.
More description
DC10036 RRx-001 Featured
RRx-001 is a novel epigenetic modulator with potential radiosensitizing activity. It inhibits glucose 6-phosphate dehydrogenase(G6PD) in human tumor cells, binds hemoglobin and drives RBC-mediated redox reactions under hypoxia.
More description
DC23090 Rubusoside Featured
Rubusoside is a natural sweetener and a solubilizing agent with antiangiogenic and antiallergic properties.Rubusoside can improve the survival rate of palmitic acid- induced INS- 1 cells and inhibit the occurrence of apoptosis.
More description
DC10622 S38093 Featured
S 38093 is a brain-penetrant antagonist of H3 receptor, with Ki of 8.8, 1.44 and 1.2 µM for rat, mouse and human H3 receptors, respectively.
More description
DC8227 SA4503 2HCl Featured
SA4503 is a selective sigma 1 receptor(σ1R) agonist; high affinity for the sigma 1 receptor subtype labeled by (+)-[3H]pentazocine (IC50 = 17.4 +/- 1.9 nM); 100-fold less affinity for the sigma 2 receptor.
More description
DC8420 Salirasib Featured
Salirasib is a potent competitive prenylated protein methyltransferase (PPMTase) inhibitor with Ki of 2.6 μM, which inhibits Ras methylation. Phase 2.
More description
DC5998 Salvianolic acid B Featured
Salvianolic acid B is a cell protective antioxidant and free radical scavenger being investigated for a variety of conditions from ischemic heart disorders to Alzheimer′s disease.
More description
DC23030 Santalol Featured
Santalol has good antibacterial, anti-oxidation and anti-tumor activities.
More description
DC10499 SAR348830 Featured
SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
More description
DC7965 SBE 13 hydrochloride Featured
SBE13 Hcl is a potent and selective PLK1 with IC50 of 0.2 nM; no inhibition om Aurora A kinase, Plk2 and Plk3.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X